Medical Voice 11th August 2020 |
Clinical News
eMediNexus Coverage from: 
Medical Voice 11th August 2020
Dr KK Aggarwal,  11 August 2020
Coronavirus Live Count Map India

remove_red_eye 561 Views
COVID-19 Vaccine Updates


0 Read Comments                

AIIMS-Patna patients to get antiviral drug for free

PATNA: Union minister of state for health and family welfare Ashwini Kumar Choubey on Sunday asked the officials of AIIMS-Patna to use antiviral drug Remdesivir on Covid-19 patients strictly as per the protocol. The drug will be made available to the patients at AIIMS-Patna on consultation with doctors free of cost, he said. ,The instruction came a day after the ministry of health and family welfare asked the state governments to make efforts to reduce Covid mortality rate. Patna is among the 13 districts in the country with high case load and fatality rate. These districts account for nearly 9% of the country’s active Covid cases and about 14% of deaths. more

Good daily diet can build your immunity and help fight COVID 19.

Join us today at 7:00 PM on MEDtalks with Dr K K Aggarwal as he discusses how to build immunity to beat COVID 19.Just click on or


CMAAO Corona Facts and Myth COVID Train Travel

With inputs from Dr Monica Vasudev1033: The risk of COVID-19 transmission in train passengers: an epidemiological and modelling study; Maogui Hu, Hui Lin, Jinfeng Wang, Chengdong Xu, et all; Clinical Infectious Diseases, 29 July 2020 Despite the trains being one of the commonest modes of public transport across the world, the risk of COVID 19 transmission among individuals traveling by train remains ambiguous. The study was conducted retrospectively to quantify the risk of spread of COVID 19 on high-speed train passengers. The data was collected from 2,334 index patients and 72,093 close contacts who travelled together for 0-8 hours from 19 December 2019 through 6 March 2020 in China. The researchers analyzed the spatial and temporal distribution of COVID 19 transmission among train passengers to assess the linkbetween infection, spatial distance and co-travel time. more

CMAAO Corona Facts and Myth COVID Informed Consent

With inputs from Dr Monica Vasudev1034: Round Table Expert Zoom Meeting on “Consent in Covid era - Need for Change” 1st August 2020, 11am-12pm,Participants: Dr KK Aggarwal, Dr AK Agarwal, Prof Mahesh Verma, Dr Ashok Gupta, Dr Shashank Joshi, Dr JA Jayalal, Dr Jayakrishnan Alapet, Dr Anil Kumar, Mrs Upasana Arora, Dr KK Kalra, Ms Ira Gupta, Dr Sanchita Sharma more

Significance of Lighting a Lamp in Any Worship

Deepajyothi parabrahmaDeepa Jyotir JanaardanahDeepo harati paapaaniSandhyaa deepa namostute“I prostrate to the dawn/dusk lamp; whose light is the Knowledge Principle (the Supreme Lord), which removes the darkness of ignorance and by which all can be achieved in life.” more

Video of The day

Covid ke dar se Aazadi

Healthcare News Monitor

Divis Labs beats drugmakers to become Indias 2nd most valuable pharma company


Divis Laboratories Ltd has become the second most valuable listed pharmaceutical company with its share price rising 65% so far in 2020, beating drugmakers like Aurobindo Pharma, Dr. Reddy’s Laboratories Ltd and Cipla Ltd that have much higher revenues. In intraday, the stock hit an all time high of ₹3,201.85, up 15% from its previous close. At 10.14 am, the scrip was trading at ₹3,117.70 on BSE, up 12.60. Currently its market cap stood at ₹82,585 crore. Sun Pharma is the most valued listed company of India with market cap of ₹1.28 trillion. In terms of revenue, Divis Lab ranks 14th. Sun Pharmaceutical continued to report highest revenue with ₹7,467.19 crore in June quarter followed by Aurobindo Pharma, Dr Reddys Labs, Cipla Ltd, Cadila Healthcare, Lupin Ltd, Piramal Enterprises, Apollo Hospital, Glenmark Pharma, Jubilant Life, Aster DM Healthcare, Torrent Pharma and Alkem Lab.

Dont want to launch Covid vaccine under pressure, says Bharat Biotech CMD

Business Standard

"The current pandemic is putting pressure on the company to come out with a vaccine quickly, but we cannot rush as safety and quality are paramount," said Krishna Ella, Chairman & MD, Bharat Biotech International. The Hyderabad-based pharma firm has completed phase-I clinical trials for its vaccine candidate against covid-19. "There is a tremendous pressure on us to develop the vaccine. But for us, safety and quality are paramount. We dont want to kill more people with the wrong vaccine," Ella said during an interaction with members of the Chennai International Centre on Covid-19 Endgame Scenarios on Saturday.

Kashmir Doctor Dies Of Covid, Had Treated Infected Patients For 4 Months


Srinagar: A doctor at the forefront of the battle against the coronavirus in Kashmir died Sunday morning after contracting the virus that has infected over 21.5 lakh people across the country, so far, and killed more than 43,000. Dr Mohammad Ashraf Mir, who health authorities said had been treating COVID-19 patients for the past four months, was admitted to the Shere Kashmir Institute of Medical Sciences in Srinagar after testing positive for the virus. He died this morning and his death has been widely mourned in Kashmir. The Valley is seeing a spike in infections with 463 new Covid cases in the past 24 hours, according to data this morning. Of these, 382 are from Kashmir and the rest from Jammu.

Bihar doctor deaths blamed on inferior PPE

The Telegraph Online

Bihar’s government doctors have pinpointed the “substandard” and “porous” personal protection equipment kits supplied to them as a key reason for the large number of medics dying or getting infected with Covid-19 in the state. “Most of the 19 doctors who have died of the coronavirus disease and the 400-plus others infected in the state are government doctors,” said Dr Sunil Kumar, private practitioner and honorary secretary of the Bihar branch of the Indian Medical Association (IMA), India’s largest association of doctors. State health department sources said the PPE kits had been provided by the Centre, which had obtained them from a PSU and other agencies.

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now